This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
home-builder: Archive
Dream Finders Gains 11% in 3 Months: Time to Buy the Stock Now?
by Shrabana Mukherjee
Can DFH's market positioning and prudent business model sustain its momentum?
CCSNegative Net Change TPHNegative Net Change MHONegative Net Change DFHNegative Net Change
home-builder
Is Vanguard Global Minimum Volatility Fund Admiral (VMNVX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VMNVX
VMNVXPositive Net Change
equity home-builder mutual-funds
Is Manning & Napier Disciplined Value I (MNDFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MNDFX
MNDFXNegative Net Change
equity home-builder mutual-funds
Should You Buy Research Solutions Inc. (RSSS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
RSSSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Cidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
CDTXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here Are 5 Construction Stocks to Explore on Increased Spending
by Sraddha Singha
Construction spending gains momentum in October 2024 due to optimism about Fed rate cuts and easing inflation.
EMEPositive Net Change FIXPositive Net Change STRLPositive Net Change MTZPositive Net Change AYINegative Net Change
construction home-builder
Are Options Traders Betting on a Big Move in Arch Capital Group (ACGL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Arch Capital Group (ACGL) stock based on the movements in the options market lately.
ACGLPositive Net Change
home-builder
Is Fidelity Select Environmental & Alternative (FSLEX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FSLEX
FSLEXPositive Net Change
equity home-builder mutual-funds
Is Vanguard Tax-Managed Cap Appreciation Institutional (VTCIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VTCIX
VTCIXPositive Net Change
equity home-builder mutual-funds
Is Permanent Portfolio Permanent I (PRPFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PRPFX
PRPFXPositive Net Change
equity home-builder mutual-funds
Is Vanguard Value Index Admiral (VVIAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VVIAX
VVIAXNegative Net Change
equity home-builder mutual-funds
Should You Buy SunCoke Energy (SXC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
SXCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Fidelity Series Growth Company (FCGSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FCGSX
FCGSXPositive Net Change
equity home-builder mutual-funds
Is ClearBridge Large Cap Growth A (SBLGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for SBLGX
SBLGXPositive Net Change
equity home-builder mutual-funds
Is Index Funds S&P 500 Equal Weight (INDEX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for INDEX
INDEXPositive Net Change
equity home-builder mutual-funds
Should You Buy BigBear.ai Holdings, Inc. (BBAI) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
BBAINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CCC Intelligent Solutions Holdings Inc. (CCCS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CCCSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, T. Rowe Price (TROW)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
TROWNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is T. Rowe Price Japan Fund (PRJPX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PRJPX
PRJPXPositive Net Change
equity home-builder mutual-funds
Is Vanguard Growth & Income Admiral (VGIAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VGIAX
VGIAXNegative Net Change
equity home-builder mutual-funds
Is Fidelity International Discovery (FIGRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FIGRX
FIGRXNegative Net Change
equity home-builder mutual-funds
Homebuilder ETFs Gain Traction
by Sweta Killa
Homebuilder ETFs have been seeing solid momentum in recent weeks given the slew of upbeat data, lower mortgage rates and Fed rate cuts.
XHBNegative Net Change ITBNegative Net Change PKBPositive Net Change IVVPositive Net Change HOMZNegative Net Change
etfs home-builder
Should You Buy Poseida Therapeutics, Inc. (PSTX) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Mairs & Power Growth Fund (MPGFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MPGFX
MPGFXPositive Net Change
equity home-builder mutual-funds
Is Fidelity Advisor Technology M (FATEX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FATEX
FATEXPositive Net Change
equity home-builder mutual-funds